A drug that halves a woman’s risk of breast cancer continues to work long after they stop taking it, say researchers. Anastrozole blocks the production of the hormone oestrogen, which fuels the growth of many breast cancers. It is already available on the NHS, but researchers at Queen Mary University of London said only a… Read More: Drug that prevents half of breast cancers carries on working »
Inspired by reports of a second patient apparently freed of infection with H.I.V., the virus that causes AIDS, scientists are pursuing dozens of ways to cure the disease. But now, researchers must reckon with a longstanding obstacle: the lack of women in clinical trials of potential H.I.V. treatments, cures and vaccines. Women make up just… Read More: Half of H.I.V. Patients Are Women. Most Research Subjects Are… »
THURSDAY, April 25, 2019 (HealthDay News) — The death rate for older Americans receiving dialysis for kidney failure may be nearly twice as high as widely thought, according to a new report. For the study, researchers looked at 391 Medicare patients, aged 65 and older, who started dialysis, in which a machine is used to… Read More: Half of Older Dialysis Patients Die Within a Year »
Dive Brief: Breaches of protected health information can seriously harm an organization’s brand and finances, but little is known about how breaches occur and the steps organizations take to prevent a recurrence, according to a research letter in JAMA Internal Medicine. The researchers analyzed 1,138 breach cases that occurred between Oct. 21, 2009, and Dec. 31,… Read More: More than half of health data breaches triggered internally, study… »